<Suppliers Price>

5-vinyluracil

Names

[ CAS No. ]:
37107-81-6

[ Name ]:
5-vinyluracil

[Synonym ]:
5-ethenyluracil
5-vinyl-1H-pyrimidine-2,4-dione
MFCD00913267
5-ethenyl-2,4(1H,3H)-pyrimidinedione
5-Vinyl-uracil
5-ethenylpyrimidine-2,4-diol

Chemical & Physical Properties

[ Density]:
1.332g/cm3

[ Melting Point ]:
>300ºC (dec.)(lit.)

[ Molecular Formula ]:
C6H6N2O2

[ Molecular Weight ]:
138.12400

[ Exact Mass ]:
138.04300

[ PSA ]:
65.72000

[ Appearance of Characters ]:
Powder

[ Index of Refraction ]:
1.606

[ Storage condition ]:
-20°C Freezer

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
26-36/37

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2933599090

Precursor & DownStream

Customs

[ HS Code ]: 2933599090

[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

A method for the rapid preparation of 5-vinyluracil in high yield.

Nucleic Acids Res. 1(1) , 105-7, (1974)

A method for the rapid preparation of the thymineanalogue, 5-vinyluracil, in 83% yield from 5-(1-hydroxyethyl)uracil via the methanesulphonyl ester is reported.

Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

Bioorg. Med. Chem. Lett. 13(5) , 867-72, (2003)

A series of tumor-activated prodrugs of the inhibitors of dihydropyrimidine dehydrogenase (DPD), an enzyme catabolizing 5-fluorouracil (5-FU: 4g), has been designed and synthesized. RO0094889 (11c) is...

Incorporation of 5-substituted uracil derivatives into nucleic acids. The isolation and gamma-radiation-sensitivity of bacteriophage T3 containing the thymine analogue 5-vinyluracil.

Biochem. J. 187(1) , 257-60, (1980)

Bacteriophage T3 was produced in a form that contained 32% of its normal DNA thymine residues replaced with 5-vinyluracil residues by infecting a thymine-requiring strain of Escherichia coli with phag...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.